Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation approach targets returning prostate cancer with fewer side effects

NCT ID NCT01923506

First seen Jan 04, 2026 · Last updated Apr 30, 2026 · Updated 17 times

Summary

This early-phase study tested a high-precision radiation technique called stereotactic body radiation therapy (SBRT) in 26 men whose prostate cancer had returned after surgery. The goal was to find the safest and most effective dose by monitoring side effects. The approach aims to deliver radiation directly to the tumor while sparing healthy tissue.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

Conditions

Explore the condition pages connected to this study.